Pipeline Portfolio & Sensitivity of the rNPV
This lesson is part of the course
In this lesson
You value Corvane Therapeutics's four-candidate pipeline, chart each asset's rNPV and test how CRV-117's value moves with peak sales and LOA.
Buy the course once for $9.99 to unlock every lesson and lab, the final exam and the certificate – lifetime access, no subscription.
Lessons in this course
- Cumulative Probability of Success by Phase Locked
- Development Cost Schedule by Phase and Year Locked
- Peak Sales Build: Patients × Share × Price × Compliance Locked
- Sales Ramp & the Loss-of-Exclusivity Cliff Locked
- Unrisked NPV: Discounting the Success Case Locked
- Risk-Adjusted NPV: Every Cash Flow × the Probability of Getting There Locked
- Licensing Deals: Upfront, Milestones, Royalties & Both Sides' rNPV Locked
- Pipeline Portfolio & Sensitivity of the rNPV Locked